[{"AccountsPayableCurrent_0_Q3_USD":6197000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":2938000.0,"OtherAssetsNoncurrent_0_Q3_USD":6237000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":11228000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":105310000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":99819000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":14480000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-247000.0,"OperatingIncomeLoss_3_Q3_USD":-245577000.0,"NetIncomeLoss_3_Q3_USD":-231237000.0,"NetIncomeLoss_1_Q3_USD":-60001000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-149595000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-18600000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":168195000.0,"LiabilitiesCurrent_0_Q3_USD":106080000.0,"OperatingIncomeLoss_1_Q3_USD":-65238000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":5237000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":14340000.0,"PaymentsToAcquireIntangibleAssets_3_Q3_USD":8000000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":69025000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":22996000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":0.0,"Revenues_3_Q3_USD":38488000.0,"Revenues_1_Q3_USD":19257000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_3_Q3_USD":15527000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_1_Q3_USD":12337000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":202394000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":61131000.0,"ReceivablesNetCurrent_0_Q3_USD":16135000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":33752000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":71428000.0,"ProceedsFromContributionsFromParent_3_Q3_USD":168195000.0,"PrepaidExpenseCurrent_0_Q3_USD":8460000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":10600000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":192959000.0,"ShareBasedCompensation_3_Q3_USD":40306000.0,"Liabilities_0_Q3_USD":251366000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":11009000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":25762000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":0.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":321000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":320000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":464000.0,"AssetsCurrent_0_Q3_USD":24595000.0,"Assets_0_Q3_USD":192959000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":40306000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":11230000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":37676000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":76273000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q3_USD":48000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":2111000.0,"CostsAndExpenses_1_Q3_USD":84495000.0,"CostsAndExpenses_3_Q3_USD":284065000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-3036000.0,"IncreaseDecreaseInOperatingLeaseLiability_3_Q3_USD":-13305000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-820000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":32066000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":607000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeTaxesPaid_3_Q3_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-231237000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-60001000.0,"Goodwill_0_Q3_USD":12056000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":28465000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":12815000.0,"Depreciation_3_Q3_USD":9700000.0,"Depreciation_1_Q3_USD":3500000.0,"InterestPaidNet_3_Q3_USD":0.0,"StockholdersEquity_0_Q3_USD":-58407000.0,"Ticker":"TSVT","CIK":"1860782","name":"2SEVENTY BIO, INC.","OfficialName":"2seventy bio Inc. Common Stock ","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"596586540.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211201"}]